TP53 and neoplasm: In the context of epistasis, however, this might be explained by the fact that in TP53 wild‐type cells, where TP53 acts as a tumor suppressor, its knockout leads to a gain of viability phenotype, which is not the case for tumor cells which already harbor mutations in TP53 (Fig EV2H).